Experience Fenwick Represents Redfin in Offering of $500M of 0.50% Convertible Senior Notes Due 2027 March 25, 2021
Blog IPO Life Sciences Outlook: COVID-19 Vaccine Innovation Could Boost IPO Numbers to Another Record High March 25, 2021
Media Coverage Fenwick's Ran Ben-Tzur Discusses the Influence of Private Investment (PIPEs) on SPAC Deals March 24, 2021
